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Objectives. We sought to determine the influence of payor status
on the use and appropriateness of cardiac procedures.
Background. The use of invasive procedures affects the cost of
cardiovascular care and may be influenced by payor status.
Methods. We compared treatment and outcomes of myocardial
infarction among four payor groups: fee for service (FFS), health
maintenance organization (HMO), Medicaid and uninsured. Mul-
tivariate comparison was performed on the use of invasive cardiac
procedures, length of hospital stay and in-hospital mortality in
17,600 patients <65 years old enrolled in the National Registry of
Myocardial Infarction from June 1994 to October 1995. To
determine the appropriateness of coronary angiography, we com-
pared its use in patients at low and high risk for cardiac events.
Results. Angiography was performed in 86% of FFS, 80% of
HMO, 61% of Medicaid and 75% of uninsured patients. FFS
patients were more likely to undergo angiography than HMO
(odds ratio [OR] 1.27, 95% confidence interval [CI] 1.13 to 1.42),
Medicaid (OR 2.43, 95% CI 2.11 to 2.81) and uninsured patients
(OR 1.99, 95% CI 1.76 to 2.25). Similar patterns for the use of
coronary revascularization were found. Among those at low risk,
FFS patients were as likely to undergo angiography as HMO
patients but more likely than Medicaid and uninsured patients.
For those at high risk, FFS patients were more likely to undergo
angiography than patients in other payor groups. Adjusted mean
length of stay (7.3 days) was similar among all payor groups, but
adjusted mortality was higher in the Medicaid group (Medicaid
vs. FFS: OR 1.55, 95% CI 1.19 to 2.01).
Conclusions. Payor status is associated with the use and
appropriateness of invasive cardiac procedures but not length of
hospital stay after myocardial infarction. The higher in-hospital
mortality in the Medicaid cohort merits further study.
(J Am Coll Cardiol 1998;31:1474–80)
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The use of invasive procedures, such as coronary angiography,
coronary angioplasty and coronary artery bypass graft surgery,
contributes substantially to the overall cost of cardiovascular
care (1). Several studies (2–6) implicate payor status as an
influence on the delivery of cardiac care. However, many of
these studies are limited by their use of administrative dis-
charge data (2–4,6) which may not allow for appropriate
adjustments for baseline differences among different payor
groups. Moreover, it is not clear whether these differences in
use of procedures reflect overutilization in one payor group or
underutilization in another.
In the present study, we used clinical data obtained through
chart review to evaluate the effect of insurance status on the
utilization and appropriateness of invasive cardiac procedures
in a national cohort of patients admitted with an acute
myocardial infarction (AMI).
Methods
National Registry of Myocardial Infarction. The National
Registry of Myocardial Infarction (NRMI) is a multicenter,
ongoing observational study designed to collect demographic,
clinical, treatment and outcome data in patients with an AMI.
Details of the first NRMI (7), which collected data from 1990
to 1994, have been described elsewhere. NRMI 2 collects more
extensive data from 1,482 hospitals (26% of all medical/
surgical hospitals [8] in the United States). Hospitals are
encouraged to enroll consecutive patients, regardless of treat-
ment strategy. To be included in the registry, patients are
required to have experienced an AMI documented by local
hospital criteria, typically with cardiac enzymes (creatine ki-
nase and its MB fraction) or electrocardiography. Data are
collected through coordinators at each institution and sent to a
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central collection center (ClinTrials Research, Inc.) for analy-
sis. Registry coordinators attend a training course and are
provided reference manuals. Double-key entry is used by the
data collection center with electronic audits to detect errors,
omissions and out of range variables. Queries are telephoned
to local coordinators for resolution. Periodic regional meetings
of registry coordinators and investigators are held to discuss
data entry and registry findings.
Payor status. Information regarding payor status was ob-
tained in 97% of registry patients. Fee for service (FFS)
patients included all patients with traditional indemnity insur-
ance, as well as those enrolled in preferred provider organiza-
tions (PPOs). Health maintenance organization (HMO) pa-
tients included those enrolled in staff, group or network model
HMOs and individual practice associations (IPA). Medicaid
patients were enrolled in state or federal programs for low
income individuals. Uninsured patients were those without
identifiable insurance.
Hospital and regional characteristics. Demographic data
characterizing registry hospital size, capability of providing
invasive cardiac procedures, teaching status and rural or urban
location were obtained from SMG Marketing Group, Inc.
Eight regions were constructed to reflect U.S. census data.
Discretionary and nondiscretionary angiography. To de-
termine the extent of discretionary cardiac catheterization, we
identified a population at low risk for future cardiac events.
The Joint Task Force of the American College of Cardiology
and the American Heart Association (ACC/AHA) considers
angiography in this group “not ordinarily justified” (9). Low
risk patients met all of the following criteria: 1) no history of
myocardial infarction (MI) or heart failure before hospital
admission; 2) Killip class I on admission; 3) no development of
heart failure, cardiogenic shock, hypotension requiring inter-
vention, recurrent ischemia or infarction or sustained ventric-
ular arrhythmia during the hospital course; 4) Q wave MI; and
5) no evidence of inducible myocardial ischemia. Because the
database did not include results of stress testing, only patients
who did not undergo stress testing fulfilled the last of these
criteria.
Conversely, the ACC/AHA task force recommends cardiac
catheterization in post-MI patients with unfavorable prognoses
in whom revascularization is likely to confer a survival benefit
(9). On this basis, we defined a catheterization as nondiscre-
tionary if patients met one of the following criteria: 1) cardio-
genic shock; 2) recurrent myocardial ischemia or MI; or 3)
clinical evidence of heart failure on admission or during the
hospital course. Patients with severe left ventricular dysfunc-
tion (left ventricular ejection fraction ,20%) or medical
comorbidities such as stroke were excluded because they may
not be suitable candidates for revascularization.
Study criteria. Patients were included in the study if they
met all of the following criteria: 1) direct admission to a
hospital capable of providing invasive cardiac procedures; 2)
age .65 years; 3) primary payor listed as FFS, HMO or
Medicaid or uninsured; 4) angioplasty not performed as pri-
mary reperfusion therapy; and 5) not transferred to another
hospital. Patients $65 years were excluded from the analysis
because Medicare was the primary payor for .90% of these
patients. Patients admitted to hospitals incapable of providing
invasive cardiac procedures or transferred to other hospitals
were excluded because the registry did not contain information
on treatment or outcome after transfer to another facility.
Analysis of data. To compare baseline differences among
the payor groups, we used the Student-Neuman-Keuls test for
continuous variables and the chi-square test with the Bonfer-
roni correction for dichotomous variables (10). Logistic models
were constructed to determine the relation between payor
status and the use of invasive cardiac procedures. Clinically
relevant variables were entered into the models regardless of p
values obtained on univariate analysis. These included hospi-
tal, regional, clinical and demographic variables present on
admission and in-hospital events that could influence the
decision to perform invasive procedures, such as thrombolytic
therapy, stroke, heart failure, cardiogenic shock, ventricular
arrhythmias, recurrent ischemia or infarction. The variable for
payor status was forced into the model as the last step.
A separate logistic model incorporating patient demo-
graphic and hospital characteristics was constructed to deter-
mine the relation between payor status and angiography in low
and high risk populations. A linear regression model was used
to determine the relation between payor status and length of
stay. Because length of stay was not normally distributed, we
used the log transformation of length of stay as the dependent
variable in this model. Clinically relevant variables present at
the time of admission, treatment variables and interaction
terms were entered into the model with payor status forced
into the model as the final step.
A logistic model incorporating variables present at the time
of admission was constructed to determine the relation be-
tween payor status and in-hospital mortality. Stepwise regres-
sion was performed, with the variable for payor status forced in
as the last step. Treatment variables found to be related to
mortality on univariate testing (aspirin, thrombolytic therapy,
heparin, beta-adrenergic blocking agents, nitroglycerin, coro-
nary angioplasty and bypass surgery) were then entered into
the model in stepwise fashion to determine their contribution
to payor-related mortality differences. Statistical analyses were
performed using Statistical Analysis Systems (SAS), version
6.04.
Abbreviations and Acronyms
ACC/AHA 5 American College of Cardiology/American Heart
Association
AMI 5 acute myocardial infarction
CI 5 confidence interval
FFS 5 fee for service
HMO 5 health maintenance organization
MI 5 myocardial infarction
NRMI 5 National Registry of Myocardial Infarction
OR 5 odds ratio
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Results
Study patients. From June 1994 to October 1995, 184,262
patients were enrolled in NRMI 2, with 55,607 patients ,65
years old directly admitted to registry hospitals. Of these
patients, approximately half (n 5 27,775) were admitted to
hospitals capable of performing invasive cardiac procedures,
with 3,875 undergoing primary angioplasty and 2,965 trans-
ferred to other facilities. Of the remaining 20,935 patients,
17,600 met payor status criteria and were included in the
analysis.
The study population of 17,600 patients included 10,498
FFS (59.6%), 3,273 HMO (18.6%), 1,354 Medicaid (7.7%) and
2,475 uninsured patients (14%). There were substantial differ-
ences in baseline characteristics between payor groups (Table
1). FFS patients were older and more likely to be white or male
than patients in other payor groups but were otherwise com-
parable to HMO patients. Medicaid patients were more likely
to be nonwhite and female, have a higher incidence of diabetes
and previous cardiovascular events and a higher heart rate and
Killip class on admission than patients in other payor groups.
Uninsured patients were younger than patients in other payor
groups. Although their Killip class and cardiac history were
similar to those of FFS and HMO patients, they were much
less likely to have undergone revascularization before the
index hospital stay.
Hospital and regional characteristics. FFS patients were
less likely to be admitted to teaching hospitals (15.6% FFS vs.
24.5% non-FFS, p , 0.001), whereas HMO patients were less
likely to be admitted to rural hospitals (1.3% HMO vs. 5.5%
non-HMO, p , 0.001). The proportion of FFS, HMO, Med-
icaid and uninsured patients varied substantially according to
region. The proportion of HMO patients was highest in the
West (25.4%) and Northeast (34.8%) and lowest in the
Southeast (10.1%).
Cardiac procedures. During the hospital stay, 81.1% of all
study patients underwent angiography, 33.3% underwent cor-
onary angioplasty, and 17.7% underwent bypass surgery. The
use of cardiac procedures differed markedly among payor
groups (Table 2). In general, angiography and revasculariza-
tion were performed more often in FFS and HMO patients
than in Medicaid and uninsured patients. FFS patients under-
went angiography and bypass surgery more often than HMO
patients, but a similar proportion underwent angioplasty. Mul-
tivariate analysis revealed that the odds of an FFS patient
undergoing angiography were 144% greater than a Medicaid
patient, 99% greater than an uninsured patient and 30%
greater than an HMO patient (all p , 0.001). Figure 1 depicts
the association of payor status with the use of angiography in
relation to several clinical factors.
Similar results were found in a multivariate analysis of
utilization of coronary revascularization procedures. FFS pa-
tients were 54% more likely than Medicaid patients and 32%
more likely than uninsured patients to undergo coronary
angioplasty (p , 0.001) but were as likely to undergo the










Age (yr)* 54.2 6 10.2 53.4 6 5.7 53.0 6 7.4 51.5 6 9.9
White race† 86.1% 80.3% 60.7% 73.1%
Male gender* 78.3% 74.7% 54.4% 75.2%
Weight (kg)‡ 86.4 6 19.7 86.5 6 16.5 82.6 6 21.2 84.3 6 19
Clinical history
Diabetes§ 19.6% 20.8% 37.4% 17.9%
MI§ 19.5% 19.5% 31.2% 18.9%
CHF§ 3.4% 3.9% 14.0% 3.3%
Angina§ 13.9% 13.6% 20.6% 11.3%
Angioplasty\ 9.8% 10.0% 10.3% 5.8%
Bypass surgery\ 10.6% 10.2% 11.2% 5.4%
Stroke§ 2.2% 3.3% 7.6% 2.4%
Admission characteristics
Pulse rate (beats/min)§ 81.3 6 20.4 81.3 6 22.8 88.6 6 25.7 83.0 6 24.7
SBP (mm Hg)¶ 143.3 6 30.6 143.2 6 28.5 141.2 6 36.7 142.2 6 34.7
Killip class I§ 89.3% 88.0% 78.1% 86.2%
Cardiogenic shock¶ 0.7% 0.9% 1.4% 1.5%
ST segment elevation‡ 51.2% 51.5% 43.7% 56.7%
MI type
Anterior\ 26.5% 25.8% 26.9% 31.6%
Q wave‡ 58.8% 57.5% 49.7% 62.7%
*p , 0.01, fee for service (FFS) versus non–fee for service and uninsured versus insured. †p , 0.01 for all groups.
‡p , 0.01, private (fee for service and health maintenance organization [HMO]) versus nonprivate (Medicaid and
uninsured) and Medicaid versus uninsured. §p , 0.01, Medicaid versus non-Medicaid. \p , 0.01, uninsured versus
insured. ¶p 5 NS. Data presented are mean value 6 SD or percent of patients. CHF 5 congestive heart failure; MI 5
myocardial infarction; SBP 5 systolic blood pressure.
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procedure as HMO patients. FFS patients were more likely to
undergo bypass surgery than HMO, Medicaid and uninsured
patients (p , 0.001), whereas Medicaid and uninsured patients
were equally likely to undergo surgical revascularization.
Discretionary and nondiscretionary angiography. Twenty
percent of the study population was at low risk and 22% at high
risk for future cardiac events. Angiography was performed in
90.4% of low risk patients (discretionary procedures) but in
only 78.1% of high risk patients (nondiscretionary procedures).
Significant differences in the use of discretionary and nondis-
cretionary angiography among the payor groups were found
(Table 3). After we adjusted for different hospital and demo-
graphic characteristics among groups, discretionary angiogra-
phy was shown to be performed more frequently in low risk
patients with FFS or HMO insurance (combined FFS and
HMO vs. combined Medicaid and uninsured patients: odds
ratio [OR] 2.61, 95% confidence interval [CI] 1.82 to 3.61). Of
note, low risk FFS and HMO patients were equally likely to
undergo angiography, as were low risk Medicaid and uninsured
patients. Multivariate adjustment revealed that nondiscretion-
ary angiography was more likely to be performed in high risk
FFS patients than in high risk HMO (OR 1.45, 95% CI 1.19 to
1.75), Medicaid (OR 3.13, 95% CI 2.50 to 3.85) or uninsured
patients (OR 2.08, 95% CI 1.69 to 2.52).
Patient outcomes. The mean length of stay was 7.2 days for
FFS patients, 6.9 days for HMO patients, 8.4 days for Medicaid
patients and 6.9 days for uninsured patients (p , 0.001).
However, in the multivariate analysis, mean length of stay (7.3
days) was similar among all payor groups (p . 0.05).
The incidence of adverse events was similar among FFS,
HMO and uninsured patients, but heart failure and death were
higher in the Medicaid group (Table 4). After adjustment of
the model for variables present on admission, Medicaid pa-
tients were more likely to die than were FFS patients (Medic-
aid vs. FFS: OR 1.55, 95% CI 1.19 to 2.01). Adjusted mortality
rates were similar among FFS, HMO and uninsured patients
(Fig. 2). After adjustment of the model for differences in
treatments, Medicaid patients were still 40% more likely to die
than either FFS, HMO or uninsured patients (Medicaid vs.
FFS: OR 1.40, 95% CI 1.04 to 1.87). Thus, process of care
accounted for some but not all of the mortality difference.
Discussion
Our findings demonstrate that payor status is strongly
associated with the use of invasive cardiac procedures in
Figure 1. Odds ratios with 95% confidence intervals for factors
influencing use of angiography in 17,600 patients admitted to the
hospital with an AMI. FFS was used as the reference category for
payor status comparisons, Great Lakes as the reference category for
regional comparisons and pulse rate 40 to 80 beats/min as the
reference category for heart rate. Odds ratios to the left of the dashed
line indicate that angiography was less likely, those to the right of the
dashed line that it was more likely. CHF 5 congestive heart failure;
SBP 5 systolic blood pressure.










Angiography* 85.5% 80.4% 61.0% 74.9%
Angioplasty† 35.6% 34.0% 20.8% 29.3%
Bypass surgery‡ 19.4% 16.1% 11.0% 13.5%
Other
Echocardiography§ 42.2% 40.8% 50.2% 44.6%
IABP\ 6.6% 5.6% 5.8% 5.2%
Mechanical ventilation¶ 18.0% 15.3% 18.4% 14.4%
Pacemaker\# 4.2% 3.2% 4.1% 4.3%
Stress testing¶ 15.4% 19.6% 16.9% 16.5%
*p , 0.01 between all groups. †p , 0.01, private versus nonprivate, Medicaid versus uninsured. ‡p , 0.01, private
versus nonprivate, fee for service (FFS) versus health maintenance organization (HMO). §p , 0.01 Medicaid versus
non-Medicaid. \p 5 NS. #Includes transvenous or permanent; data on left ventricular ejection reaction available for 65%
of study patients. ¶p , 0.01, HMO versus non-HMO. Data presented are percent of patients. IABP 5 intraaortic balloon
pump.
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patients 65 years of age. Coronary angiography, coronary
angioplasty and bypass surgery were performed more fre-
quently in patients with FFS service or HMO insurance than in
those with Medicaid or no insurance. Moreover, FFS patients
were more likely to undergo angiography and bypass surgery
than were HMO patients.
Appropriateness of invasive procedures. Although some
have recommended routine angiography in all post-MI pa-
tients (11), this approach is neither supported by randomized
trials (12,13) nor recommended by consensus panels (9,14).
The Joint Task Force of the ACC/AHA recommends angiog-
raphy in post-MI patients who are at high risk for subsequent
cardiac events but not in those with otherwise favorable
prognoses (9). Our data reveal that in a national cohort of
post-MI patients, these recommendations are not being fol-
lowed. Patients at high risk for cardiac events, in whom
revascularization would be most likely to confer a survival
benefit, were less likely to undergo cardiac catheterization than
those with a more favorable prognosis. The reasons for this are
unclear and may represent a lack of physician awareness of
guideline recommendations. Alternatively, physicians may be
reluctant to perform procedures in patients at increased risk
for a poor outcome. After Pennsylvania published risk-
adjusted mortality rates for bypass surgery, 59% of cardiolo-
gists reported increased difficulty in finding surgeons willing to
perform bypass surgery in severely ill patients (15). We hypoth-
esized that more aggressive cost-containment measures, such
as those found in many HMOs (16), would have their most
pronounced effect on the utilization of discretionary proce-
dures. Indeed, previous studies of care among HMO and FFS
systems have shown a lower use of discretionary services
among HMO patients (17,18). We were thus surprised to find
that low risk HMO and FFS patients were equally likely to
undergo discretionary angiography. In contrast, nondiscretion-
ary angiography was significantly lower in high risk HMO
patients than in similar FFS patients. This finding raises
concern because overall health care benefit may suffer if
utilization of nondiscretionary procedures is selectively re-
duced.
Financial disincentives to care for both Medicaid and
uninsured patients may make hospitals and physicians less
willing to perform invasive cardiac procedures. We demon-
strated a reduction in both discretionary and nondiscretionary
procedures in these payor groups. Nevertheless, .80% of low
risk Medicaid and uninsured patients underwent angiography.
Thus, despite financial pressures, physicians are not directing
the use of invasive procedures to those patients most likely to
benefit.
Strengths of analysis. To our knowledge, our study repre-
sents the first to investigate the influence of payor among a
national cohort of post-MI patients and the first to investigate
the appropriateness of cardiac procedure use among different










Low risk pts*† 23.5% 21.5% 14.0% 22.8%
High risk pts*† 27.2% 26.8% 34.5% 29.7%
Angiography
Discretionary (low risk pts)‡ 92.7% 92.3% 81.1% 84.0%
Nondiscretionary (high risk pts)§ 83.6% 78.0% 60.2% 72.6%
*p , 0.001, Medicaid versus non-Medicaid. †See text for definition of low and high risk. ‡p , 0.001, private
versus nonprivate. §p , 0.001 between all groups. Data presented are percent of patients (pts). Other abbreviations as
in Table 1.









Hypotension† 12.6% 12.7% 14.3% 15.1%
Recurrent angina† 13.8% 12.6% 14.5% 13.8%
Recurrent MI† 2.6% 2.6% 2.7% 1.9%
CHF‡ 8.6% 8.5% 16.0% 9.7%
Cardiogenic shock† 3.0% 2.6% 4.5% 3.6%
Sustained ventricular arrhythmia† 7.3% 6.5% 7.5% 8.0%
Cardiac rupture† 0.6% 0.4% 0.8% 1.1%
Cardiac arrest† 2.9% 3.1% 4.5% 3.7%
Stroke† 0.8% 0.9% 1.6% 0.8%
Major bleeding† 2.0% 2.2% 2.4% 1.9%
Death‡ 3.8% 3.9% 8.9% 5.4%
*Hypotension requiring intervention; major bleeding requiring transfusion. †p 5 NS. ‡p , 0.01 Medicaid versus
non-Medicaid. Abbreviations as in Table 1.
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payor groups. The strength of this analysis rests on its use of
detailed clinical data collected by trained abstractors. Several
investigators (2,4,6,19) have drawn conclusions about health
care quality using administrative discharge data, but this form
of data is controversial because it may not adequately adjust
for case mix (20,21). Our data, which included several impor-
tant clinical and physiologic variables present at the time of
admission, allow valid comparison of utilization, appropriate-
ness and outcome of care.
Length of stay. Length of hospital stay is an important
determinant of the total cost of care (22). However, we found
no significant differences in adjusted length of stay among
payor groups. Financial pressures to limit length of stay,
traditionally associated with HMO systems, are now present
among other payor groups and may well explain our findings.
Although knowledge of a patient’s coronary anatomy may
allow for earlier discharge, we found no evidence that payor
systems that used more angiography had shorter lengths of
stay.
In-hospital outcomes. Our analysis points to a higher risk-
adjusted mortality among Medicaid patients than in other
payor groups. These findings are consistent with those of a
previous study using administrative discharge data (4). The
mortality difference persisted even after incorporating treat-
ments such as coronary angioplasty and bypass surgery into the
adjustment models. Thus, we are unable to fully explain
outcome differences on the basis of treatments received. It is
unclear whether these outcome differences are due to unmea-
sured differences in quality of care or to differences in comor-
bidities not accounted for in the risk-adjustment model.
Despite a lower use of nondiscretionary angiography in
HMO and uninsured patients than in FFS patients, we found
no difference in adjusted in-hospital mortality. It is therefore
tempting to conclude that overall health care benefits did not
suffer in systems that used fewer invasive procedures. How-
ever, this finding must be viewed with caution for several
reasons: 1) Our study may not be adequately powered to detect
a mortality difference; 2) a longer follow-up period may be
necessary to show a survival benefit; and 3) we did not measure
functional status at discharge or at follow-up, an important
measure of outcome.
Study limitations. Our study has potential limitations that
merit discussion: 1) Although several quality control measures
were taken to ensure that registry data were consistent and
reliable, the data set was not validated through independent
chart review. 2) We lacked data on the treatment and outcome
of patients transferred to other acute care facilities and thus
were forced to exclude them from analysis. However, only 10%
of patients admitted to hospitals capable of providing invasive
procedures underwent transfer, with FFS patients more likely
to be transferred for procedures than patients in other payor
groups. 3) We do not have data on procedure use after
discharge. Although a previous analysis of the use of post-MI
outpatient catheterization showed no difference between FFS
and HMO plans (23), this procedure may be performed to a
varying extent among other payor groups. 4) We could not
assess the extent of patient refusal of procedures. Payor type
has been shown to influence patient behavior. In the RAND
health experiment (24), patients randomized to plans with
deductibles and copayments were less likely to use some
outpatient services. Similarly, uninsured patients, who are at full
financial liability for their medical expenses, may be reluctant to
accept expensive procedures offered them. 5) We do not have
data regarding physician form of reimbursement (e.g., salaried vs.
nonsalaried), whether HMO patients were seen on a FFS or
capitated basis or whether physicians were aware of the patient’s
insurance status at the time of decision making. All these factors
might influence the use of invasive procedures.
Finally, we did not evaluate the effect of payor on functional
status, morbidity or mortality after discharge. The mortality
benefit from surgical revascularization may not be seen for
several years (25). A study comparing practice patterns in the
United States with those in Canada (26) showed that the lower
use of invasive cardiac procedures in Canada led to measurable
differences in morbidity and functional status. We are unaware
of analyses of the effect of payor status that incorporate
measures of functional status and long-term outcomes.
Conclusions. Rising health care costs have led to dramatic
restructuring of the financing of health care in the United
States. Our findings provide some insight into the effects of
various payor arrangements on the delivery, quality and out-
come of cardiac care. The influence of payor on functional
status and long-term morbidity and mortality after MI requires
further study.
Figure 2. Odds ratios with 95% confidence intervals for factors
influencing in-hospital mortality in 17,600 patients admitted to the
hospital with an AMI. FFS was used as the reference category for
payor status comparisons, Great Lakes as the reference category for
regional comparisons and pulse rate 40 to 80 beats/min as the
reference category for heart rate. Odds ratios to the left of the dashed
line indicate that mortality was less likely, those to the right of the
dashed line that it was more likely. Abbreviations as in Figure 1.
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